<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31322104</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2165-0497</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>7</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Microbiology spectrum</Title>
          <ISOAbbreviation>Microbiol Spectr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cell Biology of Intracellular Adaptation of <i>Mycobacterium leprae</i> in the Peripheral Nervous System.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/microbiolspec.BAI-0020-2019</ELocationID>
        <Abstract>
          <AbstractText>The mammalian nervous system is invaded by a number of intracellular bacterial pathogens which can establish and progress infection in susceptible individuals. Subsequent clinical manifestation is apparent with the impairment of the functional units of the nervous system, i.e., the neurons and the supporting glial cells that produce myelin sheaths around axons and provide trophic support to axons and neurons. Most of these neurotrophic bacteria display unique features, have coevolved with the functional sophistication of the nervous system cells, and have adapted remarkably to manipulate neural cell functions for their own advantage. Understanding how these bacterial pathogens establish intracellular adaptation by hijacking endogenous pathways in the nervous system, initiating myelin damage and axonal degeneration, and interfering with myelin maintenance provides new knowledge not only for developing strategies to combat neurodegenerative conditions induced by these pathogens but also for gaining novel insights into cellular and molecular pathways that regulate nervous system functions. Since the pathways hijacked by bacterial pathogens may also be associated with other neurodegenerative diseases, it is anticipated that detailing the mechanisms of bacterial manipulation of neural systems may shed light on common mechanisms, particularly of early disease events. This chapter details a classic example of neurodegeneration, that caused by <i>Mycobacterium leprae</i>, which primarily infects glial cells of the peripheral nervous system (Schwann cells), and how it targets and adapts intracellularly by reprogramming Schwann cells to stem cells/progenitor cells. We also discuss implications of this host cell reprogramming by leprosy bacilli as a model in a wider context.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hess</LastName>
            <ForeName>Samuel</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Council (MRC) Centre for Regenerative Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rambukkana</LastName>
            <ForeName>Anura</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Council (MRC) Centre for Regenerative Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS045187</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI045816</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>MR/K017047/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/P011292/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Microbiol Spectr</MedlineTA>
        <NlmUniqueID>101634614</NlmUniqueID>
        <ISSNLinking>2165-0497</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000222" MajorTopicYN="N">Adaptation, Physiological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007918" MajorTopicYN="N">Leprosy</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009166" MajorTopicYN="N">Mycobacterium leprae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017933" MajorTopicYN="N">Peripheral Nervous System</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31322104</ArticleId>
        <ArticleId IdType="mid">NIHMS1043906</ArticleId>
        <ArticleId IdType="pmc">PMC6700727</ArticleId>
        <ArticleId IdType="doi">10.1128/microbiolspec.BAI-0020-2019</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Drevets DA, Leenen PJM, Greenfield RA. 2004. 
Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev
17:323–347
10.1128/CMR.17.2.323-347.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.17.2.323-347.2004</ArticleId>
            <ArticleId IdType="pmc">PMC387409</ArticleId>
            <ArticleId IdType="pubmed">15084504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deigendesch N, Stenzel W. 2018. 
Acute and chronic bacterial infections and sarcoidosis, p 217–226. In Handbook of Clinical Neurology. Elsevier, New York, NY.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28987171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suthar R, Sankhyan N. 2018. 
Bacterial infections of the central nervous system. Indian J Pediatr
86:60–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29297142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jessen KR, Mirsky R. 2005. 
The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci
6:671–682
10.1038/nrn1746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn1746</ArticleId>
            <ArticleId IdType="pubmed">16136171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jessen KR, Mirsky R, Lloyd AC. 2015. 
Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol
7:a020487 10.1101/cshperspect.a020487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a020487</ArticleId>
            <ArticleId IdType="pmc">PMC4484967</ArticleId>
            <ArticleId IdType="pubmed">25957303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peltonen S, Alanne M, Peltonen J. 2013. 
Barriers of the peripheral nerve. Tissue Barriers
1:e24956 10.4161/tisb.24956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/tisb.24956</ArticleId>
            <ArticleId IdType="pmc">PMC3867511</ArticleId>
            <ArticleId IdType="pubmed">24665400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reinhold AK, Rittner HL. 2017. 
Barrier function in the peripheral and central nervous system—a review. Pflugers Arch
469:123–134
10.1007/s00424-016-1920-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-016-1920-8</ArticleId>
            <ArticleId IdType="pubmed">27957611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. 2017. 
Global leprosy update, 2016: accelerating reduction of disease burden. Wkly Epidemiol Rec
92:501–519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28861986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Brakel WH, Post E, Saunderson PR, Gopal PK. 2017. 
Leprosy, p 391–401. In Quah SR (ed), International Encyclopedia of Public Health, 2nd ed
Academic Press, New York, NY.</Citation>
        </Reference>
        <Reference>
          <Citation>Browne SG. 1985. 
The history of leprosy, p 1–14. In Hastings RC (ed), Leprosy. Churchill Livingstone, Edinburgh, United Kingdom.</Citation>
        </Reference>
        <Reference>
          <Citation>Hansen GHA. 1874. 
Undersøgelser angående spedalskhedens årsager (investigations concerning the etiology of leprosy). Nor Mag Laegervidenskaben
4:1–88.</Citation>
        </Reference>
        <Reference>
          <Citation>Suzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, Ishii N. 2012. 
Current status of leprosy: epidemiology, basic science and clinical perspectives. J Dermatol
39:121–129
10.1111/j.1346-8138.2011.01370.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1346-8138.2011.01370.x</ArticleId>
            <ArticleId IdType="pubmed">21973237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. 2017. 
Global Leprosy Strategy 2016–2020. World Health Organization, Geneva, Switzerland.</Citation>
        </Reference>
        <Reference>
          <Citation>Cruz RCDS, Bührer-Sékula S, Penna MLF, Penna GO, Talhari S. 2017. 
Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. An Bras Dermatol
92:761–773
10.1590/abd1806-4841.20176724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/abd1806-4841.20176724</ArticleId>
            <ArticleId IdType="pmc">PMC5786388</ArticleId>
            <ArticleId IdType="pubmed">29364430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole ST, et al.
2001. 
Massive gene decay in the leprosy bacillus. Nature
409:1007–1011
10.1038/35059006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35059006</ArticleId>
            <ArticleId IdType="pubmed">11234002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh P, Cole ST. 2011. 
Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future Microbiol
6:57–71
10.2217/fmb.10.153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fmb.10.153</ArticleId>
            <ArticleId IdType="pmc">PMC3076554</ArticleId>
            <ArticleId IdType="pubmed">21162636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truman R. 2005. 
Leprosy in wild armadillos. Lepr Rev
76:198–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16248207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balamayooran G, Pena M, Sharma R, Truman RW. 2015. 
The armadillo as an animal model and reservoir host for Mycobacterium leprae. Clin Dermatol
33:108–115
10.1016/j.clindermatol.2014.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clindermatol.2014.07.001</ArticleId>
            <ArticleId IdType="pubmed">25432816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avanzi C, Del-Pozo J, Benjak A, Stevenson K, Simpson VR, Busso P, McLuckie J, Loiseau C, Lawton C, Schoening J, Shaw DJ, Piton J, Vera-Cabrera L, Velarde-Felix JS, McDermott F, Gordon SV, Cole ST, Meredith AL. 2016. 
Red squirrels in the British Isles are infected with leprosy bacilli. Science
354:744–747
10.1126/science.aah3783.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aah3783</ArticleId>
            <ArticleId IdType="pubmed">27846605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scollard DM, Truman RW, Ebenezer GJ. 2015. 
Mechanisms of nerve injury in leprosy. Clin Dermatol
33:46–54
10.1016/j.clindermatol.2014.07.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clindermatol.2014.07.008</ArticleId>
            <ArticleId IdType="pubmed">25432810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lázaro FP, Werneck RI, Mackert CCO, Cobat A, Prevedello FC, Pimentel RP, Macedo GMM, Eleutério MAM, Vilar G, Abel L, Xavier MB, Alcaïs A, Mira MT. 2010. 
A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil. J Infect Dis
201:1598–1605
10.1086/652007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/652007</ArticleId>
            <ArticleId IdType="pubmed">20388034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST. 2011. 
Probable zoonotic leprosy in the southern United States. N Engl J Med
364:1626–1633
10.1056/NEJMoa1010536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1010536</ArticleId>
            <ArticleId IdType="pmc">PMC3138484</ArticleId>
            <ArticleId IdType="pubmed">21524213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chopra R, Ali S, Srivastava AK, Aggarwal S, Kumar B, Manvati S, Kalaiarasan P, Jena M, Garg VK, Bhattacharya SN, Bamezai RNK. 2013. 
Mapping of PARK2 and PACRG overlapping regulatory region reveals LD structure and functional variants in association with leprosy in unrelated Indian population groups. PLoS Genet
9:e1003578 10.1371/journal.pgen.1003578.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1003578</ArticleId>
            <ArticleId IdType="pmc">PMC3701713</ArticleId>
            <ArticleId IdType="pubmed">23861666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chopra R, Kalaiarasan P, Ali S, Srivastava AK, Aggarwal S, Garg VK, Bhattacharya SN, Bamezai RNK. 2014. 
PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population. BMJ Open
4:e004239 10.1136/bmjopen-2013-004239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2013-004239</ArticleId>
            <ArticleId IdType="pmc">PMC3939656</ArticleId>
            <ArticleId IdType="pubmed">24578538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mira MT, Alcaïs A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Doré C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E. 2004. 
Susceptibility to leprosy is associated with PARK2 and PACRG. Nature
427:636–640
10.1038/nature02326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02326</ArticleId>
            <ArticleId IdType="pubmed">14737177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Domingo A, Klein C. 2018. 
Genetics of Parkinson disease, p 211–227. In Handbook of Clinical Neurology. Elsevier, New York, NY.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29325612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng L, Shen L, Ji HF. 2019. 
Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies. J Neurovirol
25:221–228
10.1007/s13365-018-0707-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13365-018-0707-4</ArticleId>
            <ArticleId IdType="pubmed">30632012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT. 2012. 
Infectious agents and neurodegeneration. Mol Neurobiol
46:614–638
10.1007/s12035-012-8320-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-012-8320-7</ArticleId>
            <ArticleId IdType="pmc">PMC3496540</ArticleId>
            <ArticleId IdType="pubmed">22899188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, Rambukkana A. 2014. 
Neurodegeneration in leprosy: insights from model systems and patients, p 217–232. In Bentivoglio M, Cavalheiro EA, Kristensson K, Patel NB (ed), Neglected Tropical Diseases and Conditions of the Nervous System. Springer, New York, NY: 
10.1007/978-1-4614-8100-3_12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4614-8100-3_12</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. 2006. 
The continuing challenges of leprosy. Clin Microbiol Rev
19:338–381
10.1128/CMR.19.2.338-381.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.19.2.338-381.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1471987</ArticleId>
            <ArticleId IdType="pubmed">16614253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truman RW, Krahenbuhl JL. 2001. 
Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis
69:1–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11480310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colston MJ, Hilson GRF. 1976. 
Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature
262:399–401
10.1038/262399a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/262399a0</ArticleId>
            <ArticleId IdType="pubmed">785274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truman RW, Ebenezer GJ, Pena MT, Sharma R, Balamayooran G, Gillingwater TH, Scollard DM, McArthur JC, Rambukkana A. 2014. 
The armadillo as a model for peripheral neuropathy in leprosy. ILAR J
54:304–314
10.1093/ilar/ilt050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ilar/ilt050</ArticleId>
            <ArticleId IdType="pmc">PMC4158350</ArticleId>
            <ArticleId IdType="pubmed">24615444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma R, Lahiri R, Scollard DM, Pena M, Williams DL, Adams LB, Figarola J, Truman RW. 2013. 
The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases. Dis Model Mech
6:19–24
10.1242/dmm.010215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dmm.010215</ArticleId>
            <ArticleId IdType="pmc">PMC3529335</ArticleId>
            <ArticleId IdType="pubmed">23223615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Job CK. 1989. 
Nerve damage in leprosy. Int J Lepr Other Mycobact Dis
57:532–539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2545801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennekens FG, van Brakel WH. 1998. 
Neuropathy in leprosy, p 319–339. In Latov N, Wokke JHJ, Kelly JJ Jr (ed), Immunological and Infectious Diseases of the Peripheral Nerves. Cambridge University Press, Cambridge, United Kingdom.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodrigues LC, Lockwood DN. 2011. 
Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis
11:464–470
10.1016/S1473-3099(11)70006-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(11)70006-8</ArticleId>
            <ArticleId IdType="pubmed">21616456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. 2017. 
Inflammatory responses and inflammation-associated diseases in organs. Oncotarget
9:7204–7218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5805548</ArticleId>
            <ArticleId IdType="pubmed">29467962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ransohoff RM. 2016. 
How neuroinflammation contributes to neurodegeneration. Science
353:777–783
10.1126/science.aag2590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aag2590</ArticleId>
            <ArticleId IdType="pubmed">27540165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoner GL. 1979. 
Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet
ii:994–996
10.1016/S0140-6736(79)92564-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(79)92564-9</ArticleId>
            <ArticleId IdType="pubmed">91779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miko TL, Le Maitre C, Kinfu Y. 1993. 
Damage and regeneration of peripheral nerves in advanced treated leprosy. Lancet
342:521–525
10.1016/0140-6736(93)91647-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0140-6736(93)91647-5</ArticleId>
            <ArticleId IdType="pubmed">8102668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ooi WW, Srinivasan J. 2004. 
Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve
30:393–409
10.1002/mus.20113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.20113</ArticleId>
            <ArticleId IdType="pubmed">15372437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A. 2001. 
Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Curr Opin Microbiol
4:21–27
10.1016/S1369-5274(00)00159-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1369-5274(00)00159-4</ArticleId>
            <ArticleId IdType="pubmed">11173029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nave K-A, Werner HB. 2014. 
Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol
30:503–533
10.1146/annurev-cellbio-100913-013101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013101</ArticleId>
            <ArticleId IdType="pubmed">25288117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira JA, Lebrun-Julien F, Suter U. 2012. 
Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci
35:123–134
10.1016/j.tins.2011.11.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tins.2011.11.006</ArticleId>
            <ArticleId IdType="pubmed">22192173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taveggia C, Feltri ML, Wrabetz L. 2010. 
Signals to promote myelin formation and repair. Nat Rev Neurol
6:276–287
10.1038/nrneurol.2010.37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2010.37</ArticleId>
            <ArticleId IdType="pmc">PMC3062363</ArticleId>
            <ArticleId IdType="pubmed">20404842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahrendsen JT, Macklin W. 2013. 
Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull
29:199–215
10.1007/s12264-013-1322-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12264-013-1322-2</ArticleId>
            <ArticleId IdType="pmc">PMC4395498</ArticleId>
            <ArticleId IdType="pubmed">23558589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitew S, Hay CM, Peckham H, Xiao J, Koenning M, Emery B. 2014. 
Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience
276:29–47
10.1016/j.neuroscience.2013.11.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2013.11.029</ArticleId>
            <ArticleId IdType="pubmed">24275321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nave KA. 2010. 
Myelination and support of axonal integrity by glia. Nature
468:244–252
10.1038/nature09614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09614</ArticleId>
            <ArticleId IdType="pubmed">21068833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng V, Zanazzi G, Timpl R, Talts JF, Salzer JL, Brennan PJ, Rambukkana A. 2000. 
Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell
103:511–524
10.1016/S0092-8674(00)00142-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)00142-2</ArticleId>
            <ArticleId IdType="pubmed">11081637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI. 1997. 
Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-α2 chain. Cell
88:811–821
10.1016/S0092-8674(00)81927-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)81927-3</ArticleId>
            <ArticleId IdType="pubmed">9118224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A, Zanazzi G, Tapinos N, Salzer JL. 2002. 
Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science
296:927–931
10.1126/science.1067631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1067631</ArticleId>
            <ArticleId IdType="pubmed">11988579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapinos N, Ohnishi M, Rambukkana A. 2006. 
ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med
12:961–966. CORRIGENDUM Nat Med 12:1100 10.1038/nm1433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1433</ArticleId>
            <ArticleId IdType="pubmed">16892039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Einheber S, Milner TA, Giancotti F, Salzer JL. 1993. 
Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol
123:1223–1236
10.1083/jcb.123.5.1223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.123.5.1223</ArticleId>
            <ArticleId IdType="pmc">PMC2119881</ArticleId>
            <ArticleId IdType="pubmed">8245127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. 1983. 
In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci USA
80:3850–3854
10.1073/pnas.80.12.3850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.80.12.3850</ArticleId>
            <ArticleId IdType="pmc">PMC394150</ArticleId>
            <ArticleId IdType="pubmed">6344090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaakkola S, Peltonen J, Riccardi V, Chu ML, Uitto J. 1989. 
Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures. J Clin Invest
84:253–261
10.1172/JCI114148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI114148</ArticleId>
            <ArticleId IdType="pmc">PMC303977</ArticleId>
            <ArticleId IdType="pubmed">2500456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanes JR, Engvall E, Butkowski R, Hunter DD. 1990. 
Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol
111:1685–1699
10.1083/jcb.111.4.1685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.111.4.1685</ArticleId>
            <ArticleId IdType="pmc">PMC2116223</ArticleId>
            <ArticleId IdType="pubmed">2211832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Meneguzzi G, Paulsson M, Sanes J, Timpl R, Tryggvason K, Yamada Y, Yurchenco PD. 1994. 
A new nomenclature for the laminins. Matrix Biol
14:209–211
10.1016/0945-053X(94)90184-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0945-053X(94)90184-8</ArticleId>
            <ArticleId IdType="pubmed">7921537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engvall E, Wewer UM. 1996. 
Domains of laminin. J Cell Biochem
61:493–501
10.1002/(SICI)1097-4644(19960616)61:4&amp;lt;493::AID-TCB2&amp;gt;3.0.CO;2-J.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-4644(19960616)61:4&amp;lt;493::AID-TCB2&amp;gt;3.0.CO;2-J</ArticleId>
            <ArticleId IdType="pubmed">8806072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Timpl R, Brown JC. 1994. 
The laminins. Matrix Biol
14:275–281
10.1016/0945-053X(94)90192-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0945-053X(94)90192-9</ArticleId>
            <ArticleId IdType="pubmed">7827749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leivo I, Engvall E. 1988. 
Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA
85:1544–1548
10.1073/pnas.85.5.1544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.85.5.1544</ArticleId>
            <ArticleId IdType="pmc">PMC279809</ArticleId>
            <ArticleId IdType="pubmed">3278318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yurchenco PD, O’Rear JJ. 1994. 
Basal lamina assembly. Curr Opin Cell Biol
6:674–681
10.1016/0955-0674(94)90093-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0955-0674(94)90093-0</ArticleId>
            <ArticleId IdType="pubmed">7833047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aumailley M, Smyth N. 1998. 
The role of laminins in basement membrane function. J Anat
193:1–21
10.1046/j.1469-7580.1998.19310001.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1469-7580.1998.19310001.x</ArticleId>
            <ArticleId IdType="pmc">PMC1467819</ArticleId>
            <ArticleId IdType="pubmed">9758133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki T, Timpl R. 1999. 
Laminins, p 434–443. In Kreis T, Vale R (ed), Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins, 3rd ed
Oxford University Press, Oxford, United Kingdom.</Citation>
        </Reference>
        <Reference>
          <Citation>Bunge MB, Bunge RP. 1986. 
Linkage between Schwann cell extracellular matrix production and ensheathment function. Ann N Y Acad Sci 486(1 Neurofibromat):241–247
10.1111/j.1749-6632.1986.tb48077.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1986.tb48077.x</ArticleId>
            <ArticleId IdType="pubmed">3471156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henry MD, Campbell KP. 1999. 
Dystroglycan inside and out. Curr Opin Cell Biol
11:602–607
10.1016/S0955-0674(99)00024-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0955-0674(99)00024-1</ArticleId>
            <ArticleId IdType="pubmed">10508656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talts JF, Andac Z, Göhring W, Brancaccio A, Timpl R. 1999. 
Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J
18:863–870
10.1093/emboj/18.4.863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/18.4.863</ArticleId>
            <ArticleId IdType="pmc">PMC1171179</ArticleId>
            <ArticleId IdType="pubmed">10022829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hohenester E, Tisi D, Talts JF, Timpl R. 1999. 
The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminins, perlecan, and agrin. Mol Cell
4:783–792
10.1016/S1097-2765(00)80388-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(00)80388-3</ArticleId>
            <ArticleId IdType="pubmed">10619025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tisi D, Talts JF, Timpl R, Hohenester E. 2000. 
Structure of the C-terminal laminin G-like domain pair of the laminin α2 chain harbouring binding sites for α-dystroglycan and heparin. EMBO J
19:1432–1440
10.1093/emboj/19.7.1432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/19.7.1432</ArticleId>
            <ArticleId IdType="pmc">PMC310212</ArticleId>
            <ArticleId IdType="pubmed">10747011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A. 2000. 
How does Mycobacterium leprae target the peripheral nervous system?
Trends Microbiol
8:23–28
10.1016/S0966-842X(99)01647-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0966-842X(99)01647-9</ArticleId>
            <ArticleId IdType="pubmed">10637640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marques MAM, Antônio VL, Sarno EN, Brennan PJ, Pessolani MCV. 2001. 
Binding of α2-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells. J Med Microbiol
50:23–28
10.1099/0022-2615-50-1-23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/0022-2615-50-1-23</ArticleId>
            <ArticleId IdType="pubmed">11192500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson RJ. 1932. 
The chemistry of the lipoids of tubercle bacilli. Physiol Rev
12:166–189
10.1152/physrev.1932.12.2.166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.1932.12.2.166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter SW, Brennan PJ. 1981. 
A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol
147:728–735.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC216107</ArticleId>
            <ArticleId IdType="pubmed">7024248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter SW, Fujiwara T, Brennan PJ. 1982. 
Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem
257:15072–15078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6184369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brennan PJ. 1989. 
Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis
11(Suppl 2): S420–S430
10.1093/clinids/11.Supplement_2.S420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/clinids/11.Supplement_2.S420</ArticleId>
            <ArticleId IdType="pubmed">2469120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rastogi N, Frehel C, David HL. 1986. 
Triple-layered structure of mycobacterial cell wall: evidence for the existence of a polysaccharide-rich outer layer in 18 mycobacterial species. Curr Microbiol
13:237–242
10.1007/BF01568645.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01568645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neill MA, Klebanoff SJ. 1988. 
The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages. J Exp Med
167:30–42
10.1084/jem.167.1.30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.167.1.30</ArticleId>
            <ArticleId IdType="pmc">PMC2188820</ArticleId>
            <ArticleId IdType="pubmed">2826638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young DB, Buchanan TM. 1983. 
A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science
221:1057–1059
10.1126/science.6348948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.6348948</ArticleId>
            <ArticleId IdType="pubmed">6348948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlesinger LS, Horwitz MA. 1991. 
Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med
174:1031–1038
10.1084/jem.174.5.1031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.174.5.1031</ArticleId>
            <ArticleId IdType="pmc">PMC2118995</ArticleId>
            <ArticleId IdType="pubmed">1940785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A. 2004. 
Mycobacterium leprae-induced demyelination: a model for early nerve degeneration. Curr Opin Immunol
16:511–518
10.1016/j.coi.2004.05.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coi.2004.05.021</ArticleId>
            <ArticleId IdType="pubmed">15245748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E. 1990. 
Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA
87:3264–3268
10.1073/pnas.87.9.3264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.87.9.3264</ArticleId>
            <ArticleId IdType="pmc">PMC53880</ArticleId>
            <ArticleId IdType="pubmed">2185464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talts JF, Timpl R. 1999. 
Mutation of a basic sequence in the laminin α2LG3 module leads to a lack of proteolytic processing and has different effects on β1 integrin-mediated cell adhesion and α-dystroglycan binding. FEBS Lett
458:319–323
10.1016/S0014-5793(99)01180-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(99)01180-1</ArticleId>
            <ArticleId IdType="pubmed">10570932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talts JF, Mann K, Yamada Y, Timpl R. 1998. 
Structural analysis and proteolytic processing of recombinant G domain of mouse laminin α2 chain. FEbS Lett
426:71–76
10.1016/S0014-5793(98)00312-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(98)00312-3</ArticleId>
            <ArticleId IdType="pubmed">9598981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernier SM, Utani A, Sugiyama S, Doi T, Polistina C, Yamada Y. 1995. 
Cloning and expression of laminin α2 chain (M-chain) in the mouse. Matrix Biol
14:447–455
10.1016/0945-053X(95)90002-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0945-053X(95)90002-0</ArticleId>
            <ArticleId IdType="pubmed">7795883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki M, Kleinman HK, Huber H, Deutzmann R, Yamada Y. 1988. 
Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem
263:16536–16544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3182802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR. 1990. 
Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul
1:731–740
10.1091/mbc.1.10.731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.1.10.731</ArticleId>
            <ArticleId IdType="pmc">PMC361653</ArticleId>
            <ArticleId IdType="pubmed">2099832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patton BL, Miner JH, Chiu AY, Sanes JR. 1997. 
Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol
139:1507–1521
10.1083/jcb.139.6.1507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.139.6.1507</ArticleId>
            <ArticleId IdType="pmc">PMC2132624</ArticleId>
            <ArticleId IdType="pubmed">9396756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell KP. 1995. 
Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell
80:675–679
10.1016/0092-8674(95)90344-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(95)90344-5</ArticleId>
            <ArticleId IdType="pubmed">7889563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA. 1998. 
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science
282:2076–2079
10.1126/science.282.5396.2076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.282.5396.2076</ArticleId>
            <ArticleId IdType="pubmed">9851927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. 
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature
355:696–702
10.1038/355696a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/355696a0</ArticleId>
            <ArticleId IdType="pubmed">1741056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LVB, Fujita S, Fukuta-Ohi H, Shimizu T, Ruegg MA, Matsumura K. 1996. 
Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem
271:23418–23423
10.1074/jbc.271.38.23418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.271.38.23418</ArticleId>
            <ArticleId IdType="pubmed">8798547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito F, Masaki T, Kamakura K, Anderson LVB, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumura K. 1999. 
Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J Biol Chem
274:8240–8246
10.1074/jbc.274.12.8240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.12.8240</ArticleId>
            <ArticleId IdType="pubmed">10075729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nave K-A, Trapp BD. 2008. 
Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci
31:535–561
10.1146/annurev.neuro.30.051606.094309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.neuro.30.051606.094309</ArticleId>
            <ArticleId IdType="pubmed">18558866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nave K-A, Salzer JL. 2006. 
Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol
16:492–500
10.1016/j.conb.2006.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.conb.2006.08.008</ArticleId>
            <ArticleId IdType="pubmed">16962312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemke G. 2006. 
Neuregulin-1 and myelination. Sci STKE 2006:pe11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16522871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, Yamaai T, Lewin GR, Birchmeier C. 1997. 
Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature
389:725–730
10.1038/39593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/39593</ArticleId>
            <ArticleId IdType="pubmed">9338783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garratt AN, Britsch S, Birchmeier C. 2000. 
Neuregulin, a factor with many functions in the life of a Schwann cell. BioEssays
22:987–996
10.1002/1521-1878(200011)22:11&amp;lt;987::AID-BIES5&amp;gt;3.0.CO;2-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1521-1878(200011)22:11&amp;lt;987::AID-BIES5&amp;gt;3.0.CO;2-5</ArticleId>
            <ArticleId IdType="pubmed">11056475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. 2005. 
Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci
25:3478–3487
10.1523/JNEUR0SCI.3766-04.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUR0SCI.3766-04.2005</ArticleId>
            <ArticleId IdType="pmc">PMC6724908</ArticleId>
            <ArticleId IdType="pubmed">15800203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yarden Y, Sliwkowski MX. 2001. 
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol
2:127–137
10.1038/35052073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35052073</ArticleId>
            <ArticleId IdType="pubmed">11252954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hynes NE, Lane HA. 2005. 
ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer
5:341–354
10.1038/nrc1609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc1609</ArticleId>
            <ArticleId IdType="pubmed">15864276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rambukkana A. 2010. 
Usage of signaling in neurodegeneration and regeneration of peripheral nerves by leprosy bacteria. Prog Neurobiol
91:102–107
10.1016/j.pneurobio.2009.12.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pneurobio.2009.12.002</ArticleId>
            <ArticleId IdType="pubmed">20005916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waxman SG. 1998. 
Demyelinating diseases—new pathological insights, new therapeutic targets. N Engl J Med
338:323–325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9445415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hess S, Rambukkana A. 2015. 
Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions. Curr Opin Microbiol
23:179–188
10.1016/j.mib.2014.11.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mib.2014.11.021</ArticleId>
            <ArticleId IdType="pmc">PMC4323685</ArticleId>
            <ArticleId IdType="pubmed">25541240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madigan CA, Cambier CJ, Kelly-Scumpia KM, Scumpia PO, Cheng TY, Zailaa J, Bloom BR, Moody DB, Smale ST, Sagasti A, Modlin RL, Ramakrishnan L. 2017. 
A macrophage response to Mycobacterium leprae phenolic glycolipid initiates nerve damage in leprosy. Cell
170:973–985. E10 10.1016/j.cell.2017.07.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.07.030</ArticleId>
            <ArticleId IdType="pmc">PMC5848073</ArticleId>
            <ArticleId IdType="pubmed">28841420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HA, Mindos T, Parkinson DB. 2013. 
Plastic fantastic: Schwann cells and repair of the peripheral nervous system. Stem Cells Transl Med
2:553–557
10.5966/sctm.2013-0011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5966/sctm.2013-0011</ArticleId>
            <ArticleId IdType="pmc">PMC3726134</ArticleId>
            <ArticleId IdType="pubmed">23817134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jessen KR, Mirsky R. 2016. 
The repair Schwann cell and its function in regenerating nerves. J Physiol
594:3521–3531
10.1113/JP270874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/JP270874</ArticleId>
            <ArticleId IdType="pmc">PMC4929314</ArticleId>
            <ArticleId IdType="pubmed">26864683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapinos N, Rambukkana A. 2005. 
Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc Natl Acad Sci USA
102:9188–9193
10.1073/pnas.0501196102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0501196102</ArticleId>
            <ArticleId IdType="pmc">PMC1166596</ArticleId>
            <ArticleId IdType="pubmed">15967991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HA, Pomeroy SL, Whoriskey W, Pawlitzky I, Benowitz LI, Sicinski P, Stiles CD, Roberts TM. 2000. 
A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron
26:405–416
10.1016/S0896-6273(00)81173-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0896-6273(00)81173-3</ArticleId>
            <ArticleId IdType="pubmed">10839359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoll G, Jander S, Myers RR. 2002. 
Degeneration and regeneration of the peripheral nervous system: From Augustus Waller’s observations to neuroinflammation. J Peripher Nerv Syst
7:13–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11939348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A. 2013. 
Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell
152:51–67
10.1016/j.cell.2012.12.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.12.014</ArticleId>
            <ArticleId IdType="pmc">PMC4314110</ArticleId>
            <ArticleId IdType="pubmed">23332746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, Lloyd AC. 2004. 
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J
23:3061–3071
10.1038/sj.emboj.7600309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7600309</ArticleId>
            <ArticleId IdType="pmc">PMC514926</ArticleId>
            <ArticleId IdType="pubmed">15241478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearson JM, Rees RJ, Weddell AG. 1970. 
Mycobacterium leprae in the striated muscle of patients with leprosy. Lepr Rev
41:155–166
10.5935/0305-7518.19700023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5935/0305-7518.19700023</ArticleId>
            <ArticleId IdType="pubmed">4923504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werneck LC, Teive HA, Scola RH. 1999. 
Muscle involvement in leprosy. Study of the anterior tibial muscle in 40 patients. Arq Neuropsiquiatr
57(3B):723–734
10.1590/S0004-282X1999000500001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0004-282X1999000500001</ArticleId>
            <ArticleId IdType="pubmed">10751905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, McGlinchey A, Tomlinson SR, Qu J, Rambukkana A. 2013. 
Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts. F1000 Res
2:198
10.12688/f1000research.2-198.v1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.2-198.v1</ArticleId>
            <ArticleId IdType="pmc">PMC3829123</ArticleId>
            <ArticleId IdType="pubmed">24358891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finzsch M, Schreiner S, Kichko T, Reeh P, Tamm ER, Bösl MR, Meijer D, Wegner M. 2010. 
Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol
189:701–712
10.1083/jcb.200912142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200912142</ArticleId>
            <ArticleId IdType="pmc">PMC2872908</ArticleId>
            <ArticleId IdType="pubmed">20457761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bremer M, Fröb F, Kichko T, Reeh P, Tamm ER, Suter U, Wegner M. 2011. 
Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia
59:1022–1032
10.1002/glia.21173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.21173</ArticleId>
            <ArticleId IdType="pubmed">21491499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M. 2001. 
The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev
15:66–78
10.1101/gad.186601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.186601</ArticleId>
            <ArticleId IdType="pmc">PMC312607</ArticleId>
            <ArticleId IdType="pubmed">11156606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirsky R, Woodhoo A, Parkinson DB, Arthur-Farraj P, Bhaskaran A, Jessen KR. 2008. 
Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation. J Peripher Nerv Syst
13:122–135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18601657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fröb F, Bremer M, Finzsch M, Kichko T, Reeh P, Tamm ER, Charnay P, Wegner M. 2012. 
Establishment of myelinating Schwann cells and barrier integrity between central and peripheral nervous systems depend on Sox10. Glia
60:806–819
10.1002/glia.22310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22310</ArticleId>
            <ArticleId IdType="pubmed">22337526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le N, Nagarajan R, Wang JYT, Araki T, Schmidt RE, Milbrandt J. 2005. 
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA
102:2596–2601
10.1073/pnas.0407836102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0407836102</ArticleId>
            <ArticleId IdType="pmc">PMC548989</ArticleId>
            <ArticleId IdType="pubmed">15695336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jessen KR, Mirsky R. 2008. 
Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia
56:1552–1565
10.1002/glia.20761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20761</ArticleId>
            <ArticleId IdType="pubmed">18803323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts SL, Dun XP, Doddrell RDS, Mindos T, Drake LK, Onaitis MW, Florio F, Quattrini A, Lloyd AC, D’Antonio M, Parkinson DB. 2017. 
Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve. Development
144:3114–3125
10.1242/dev.150656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.150656</ArticleId>
            <ArticleId IdType="pmc">PMC5611958</ArticleId>
            <ArticleId IdType="pubmed">28743796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers I, Tomlinson SR. 2009. 
The transcriptional foundation of pluripotency. Development
136:2311–2322
10.1242/dev.024398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.024398</ArticleId>
            <ArticleId IdType="pmc">PMC2729344</ArticleId>
            <ArticleId IdType="pubmed">19542351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. 2006. 
A protein interaction network for pluripotency of embryonic stem cells. Nature
444:364–368
10.1038/nature05284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature05284</ArticleId>
            <ArticleId IdType="pubmed">17093407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyagi S, Masui S, Niwa H, Saito T, Shimazaki T, Okano H, Nishimoto M, Muramatsu M, Iwama A, Okuda A. 2008. 
Consequence of the loss of Sox2 in the developing brain of the mouse. FEBS Lett
582:2811–2815
10.1016/j.febslet.2008.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2008.07.011</ArticleId>
            <ArticleId IdType="pubmed">18638478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Favaro R, Valotta M, Ferri ALM, Latorre E, Mariani J, Giachino C, Lancini C, Tosetti V, Ottolenghi S, Taylor V, Nicolis SK. 2009. 
Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci
12:1248–1256
10.1038/nn.2397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.2397</ArticleId>
            <ArticleId IdType="pubmed">19734891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komitova M, Eriksson PS. 2004. 
Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain. Neurosci Lett
369:24–27
10.1016/i.neulet.2004.07.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/i.neulet.2004.07.035</ArticleId>
            <ArticleId IdType="pubmed">15380301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavallaro M, Mariani J, Lancini C, Latorre E, Caccia R, Gullo F, Valotta M, DeBiasi S, Spinardi L, Ronchi A, Wanke E, Brunelli S, Favaro R, Ottolenghi S, Nicolis SK. 2008. 
Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. Development
135:541–557
10.1242/dev.010801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.010801</ArticleId>
            <ArticleId IdType="pubmed">18171687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez-López S, Wiskow O, Favaro R, Nicolis SK, Price DJ, Pollard SM, Smith A. 2011. 
Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells in vitro. Glia
59:1588–1599
10.1002/glia.21201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.21201</ArticleId>
            <ArticleId IdType="pubmed">21766338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cimadamore F, Fishwick K, Giusto E, Gnedeva K, Cattarossi G, Miller A, Pluchino S, Brill LM, Bronner-Fraser M, Terskikh AV. 2011. 
Human ESC-derived neural crest model reveals a key role for SOX2 in sensory neurogenesis. Cell Stem Cell
8:538–551
10.1016/i.stem.2011.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/i.stem.2011.03.011</ArticleId>
            <ArticleId IdType="pmc">PMC4110917</ArticleId>
            <ArticleId IdType="pubmed">21549328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, Pevny LH. 2006. 
SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev
20:1187–1202
10.1101/gad.1407906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1407906</ArticleId>
            <ArticleId IdType="pmc">PMC1472477</ArticleId>
            <ArticleId IdType="pubmed">16651659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surzenko N, Crowl T, Bachleda A, Langer L, Pevny L. 2013. 
SOX2 maintains the quiescent progenitor cell state of postnatal retinal Muller glia. Development
140:1445–1456
10.1242/dev.071878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.071878</ArticleId>
            <ArticleId IdType="pmc">PMC3596988</ArticleId>
            <ArticleId IdType="pubmed">23462474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaenisch R, Young R. 2008. 
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell
132:567–582
10.1016/j.cell.2008.01.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.01.015</ArticleId>
            <ArticleId IdType="pmc">PMC4142810</ArticleId>
            <ArticleId IdType="pubmed">18295576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Chu J, Shen X, Wang J, Orkin SH. 2008. 
An extended transcriptional network for pluripotency of embryonic stem cells. Cell
132:1049–1061
10.1016/j.cell.2008.02.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.02.039</ArticleId>
            <ArticleId IdType="pmc">PMC3837340</ArticleId>
            <ArticleId IdType="pubmed">18358816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young RA. 2011. 
Control of the embryonic stem cell state. Cell
144:940–954
10.1016/j.cell.2011.01.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2011.01.032</ArticleId>
            <ArticleId IdType="pmc">PMC3099475</ArticleId>
            <ArticleId IdType="pubmed">21414485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, Park PJ, Daley GQ. 2015. 
Hallmarks of pluripotency. Nature
525:469–478. CORRIGENDUM Nature 531:400 10.1038/nature15515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature15515</ArticleId>
            <ArticleId IdType="pubmed">26399828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lodato MA, Ng CW, Wamstad JA, Cheng AW, Thai KK, Fraenkel E, Jaenisch R, Boyer LA. 2013. 
SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. PLoS Genet
9:e1003288 10.1371/journal.pgen.1003288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1003288</ArticleId>
            <ArticleId IdType="pmc">PMC3578749</ArticleId>
            <ArticleId IdType="pubmed">23437007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. 2003. 
Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev
17:126–140
10.1101/gad.224503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.224503</ArticleId>
            <ArticleId IdType="pmc">PMC195970</ArticleId>
            <ArticleId IdType="pubmed">12514105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandel M, Geijsen N, Hochedlinger K. 2011. 
Sox2+ adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell
9:317–329
10.1016/j.stem.2011.09.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2011.09.001</ArticleId>
            <ArticleId IdType="pmc">PMC3538360</ArticleId>
            <ArticleId IdType="pubmed">21982232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, McMahon A, Rao M, Pevny L. 2004. 
SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci
26:148–165
10.1159/000082134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000082134</ArticleId>
            <ArticleId IdType="pubmed">15711057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim J, Thiery JP. 2012. 
Epithelial-mesenchymal transitions: insights from development. Development
139:3471–3486
10.1242/dev.071209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.071209</ArticleId>
            <ArticleId IdType="pubmed">22949611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masaki T, McGlinchey A, Cholewa-Waclaw J, Qu J, Tomlinson SR, Rambukkana A. 2014. 
Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. Cell Reprogram
16:9–17
10.1089/cell.2013.0064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cell.2013.0064</ArticleId>
            <ArticleId IdType="pmc">PMC3920758</ArticleId>
            <ArticleId IdType="pubmed">24279882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Modlin RL, Rea TH. 1988. 
Immunopathology of leprosy granulomas. Springer Semin Immunopathol
10:359–374
10.1007/BF02053846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02053846</ArticleId>
            <ArticleId IdType="pubmed">3065952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan J, Flynn J. 2004. 
The immunological aspects of latency in tuberculosis. Clin Immunol
110:2–12
10.1016/S1521-6616(03)00210-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1521-6616(03)00210-9</ArticleId>
            <ArticleId IdType="pubmed">14986673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bold TD, Ernst JD. 2009. 
Who benefits from granulomas, mycobacteria or host?
Cell
136:17–19
10.1016/j.cell.2008.12.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.12.032</ArticleId>
            <ArticleId IdType="pmc">PMC4214211</ArticleId>
            <ArticleId IdType="pubmed">19135882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW. 2001. 
Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol
158:1503–1515
10.1016/S0002-9440(10)64101-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)64101-6</ArticleId>
            <ArticleId IdType="pmc">PMC1891908</ArticleId>
            <ArticleId IdType="pubmed">11290568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiu B-C, Freeman CM, Stolberg VR, Hu JS, Komuniecki E, Chensue SW. 2004. 
The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function. Am J Pathol
164:1021–1030
10.1016/S0002-9440(10)63189-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)63189-6</ArticleId>
            <ArticleId IdType="pmc">PMC1599790</ArticleId>
            <ArticleId IdType="pubmed">14982855</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
